Royalty Term. The Royalty Payments for Product shall start two years after first commercial launch and continue for ​ years, and thereafter the License shall become royalty-free and perpetual for Product

“Royalty Territory” means the Territory, other than the Profit Share Territory.

Royalty Term. AzurRx shall pay to FWB the royalties set forth in [Section 6.4.1] commencing on the First Commercial Sale of the applicable Product in such country and expiring on the date that is the later of: # the last to expire Valid Claim in such country, # expiration of regulatory exclusivity for the applicable Product in the applicable country and # the ten (10) year anniversary of the First Commercial Sale of such Product in such country (the “Royalty Term”).

Royalty Term. “Royalty Term” means:

Royalty Term. Royalties payable under Section II(a) (Royalty Payments) shall be paid by INNOCOLL on a ​ from the ​ in the ​ until the ​: # ​of the last ​ of a ​ the ​ of such ​ in the ​, # the ​ for such ​ in the ​, and # ​ from the ​ of the ​.

Royalty Term. On a country-by-country and Product-by-Product basis, Coya’s obligation to pay Royalties for a Product in a country in the Territory shall commence upon the First Commercial Sale of such Product in such country and shall expire upon the later of: # the expiration of the last-to-expire Valid Claim in an ARScience Bio Patent that Covers such Product in such country; # the expiration of all regulatory exclusivity including data exclusivity periods, if any, for such Product in such country; and # the tenth anniversary of the First Commercial Sale of such Product in such country (the applicable “Royalty Term”). Upon expiration of the Royalty Term for a given Product in a given country # no further Royalties will be payable in respect of sales of such Product in such country, and # the licenses granted to Coya under Section 2.2.1 (Exploitation License) with respect to the Exploitation of such Product in such country will automatically become fully paid-up, perpetual, irrevocable, and royalty free. For clarity, only a single Royalty will be payable as a result of one or more Valid Claims in an ARScience Bio Patent that Covers such Product in such country during the applicable Royalty Term.

Royalty Term. The royalty payments payable under this [Section 9.3] shall be payable on a Licensed Product-by-Licensed Product and region-by-region basis from the First Commercial Sale of such Licensed Product in such region in the Territory until the latest of: # the ​ anniversary of the date of the First Commercial Sale of such Licensed Product in such region; # the expiration of the last Valid Claim (including any patent term adjustments or extensions) within the NVCR Patents that Covers such Licensed Product (including composition of matter, method of use or making) in such region and # the last to expire regulatory exclusivity period for such Licensed Product (the “Royalty Term”).

Royalty Term. Royalties will be payable on a Licensed Product-by-Licensed Product and country-by-country basis from the date of the First Commercial Sale of a Licensed Product until the later of # ten (10) years from First Commercial Sale of such Licensed Product in such country, # expiry of the last Valid Claim of any Licensed Patent Rights […​…] or # the expiration of regulatory exclusivity for such Licensed Product in such country (the “Royalty Term”).

On a Product-by-Product and country-by-country basis, Roche shall pay to Atea royalties on Net Sales of Products in such country in the Roche Royalty Territory during the relevant Royalty Term. Thereafter, the licenses granted to Roche for a given Product in such country shall be fully paid up, irrevocable and royalty-free.

Royalty Term. Licensee shall have no obligation to pay any Royalty with respect to Net Sales of any Licensed Product in any country after the last day of the month in which the Royalty Term for such Licensed Product in such country expires.